The US may experience limited shortages of drugs as manufacturing facilities in Puerto Rico struggle with power and related hurricane damage, said FDA Commissioner Scott Gottlieb, and the shortages could involve around 40 drugs, including those for HIV, rheumatoid arthritis and cancer. Merck said it is operating with generator power, and Bristol-Myers Squibb and Amgen said they do not expect an impact on patient supplies.
FDA: Puerto Rico disruptions could mean some drug shortages
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.